Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2014
10/14/2014US8859616 Compounds and methods for enhancing hair growth
10/14/2014US8859615 Compounds, compositions and methods for reducing toxicity and treating or preventing diseases
10/14/2014US8859614 Analogues of (−)-picropodophyllin, synthesis and uses thereof
10/14/2014US8859613 Compositions for the treatment of kidney disease
10/14/2014US8859612 Use of hesperidin or one of its derivatives for making a medicine for bone formation stimulation
10/14/2014US8859611 Thiophene inhibitors of S-nitrosoglutathione reductase
10/14/2014US8859610 Crystalline glycopyrrolate tosylate
10/14/2014US8859609 Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes
10/14/2014US8859608 Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction
10/14/2014US8859606 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response
10/14/2014US8859604 Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid
10/14/2014US8859603 Method for solubilizing metronidazole
10/14/2014US8859602 Inhibitors of c-fms kinase
10/14/2014US8859601 Substituted benzyl and phenylsulfonyl triazolones, and use thereof
10/14/2014US8859600 Acetone solvate crystals of trityl olmesartan medoxomil
10/14/2014US8859599 Androgen receptor modulating compounds, preparation and uses thereof
10/14/2014US8859598 1, 2, 4-oxadiazoles azetidine derivatives as sphingosine-1 phosphate receptors modulators
10/14/2014US8859597 Compounds that enhance Atoh1 expression
10/14/2014US8859596 Compounds as cannabinoid receptor ligands
10/14/2014US8859595 Potent and selective inhibitors of hepatitis C virus
10/14/2014US8859594 Polymorphs of N-(6-(4-chlorophenoxy)hexyl)-N′-cyano-N″-(4-pyridyl)guanidine, and preparation thereof and use thereof
10/14/2014US8859593 Composition for improving cognition and memory
10/14/2014US8859591 Glucagon receptor modulators
10/14/2014US8859590 Inhibitors of BACE1 and methods for treating Alzheimer's disease
10/14/2014US8859589 Use of 4′-thio-2′-deoxynucleosides as anti orthopoxvirus agents
10/14/2014US8859588 Substituted N-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof
10/14/2014US8859587 (2E)-3-phenyl-N-[2,2,2-Trifluoro-1-[[8-quinolineamino)thiomethyl]amino]ethyl]-2-acrylamide and pharmaceutical uses thereof
10/14/2014US8859586 Cyclohexyl isoquinolinone compounds
10/14/2014US8859585 Scopolamine for the treatment of depression and anxiety
10/14/2014US8859584 TRPV1 antagonists
10/14/2014US8859583 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
10/14/2014US8859582 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
10/14/2014US8859581 Azaheterocyclic compounds as kinase inhibitors
10/14/2014US8859579 Compostions and methods for preventing and/or treating disorders associated with cephalic pain
10/14/2014US8859578 Natural product derivatives with antiprotozoal activity
10/14/2014US8859577 N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors
10/14/2014US8859576 Method of treating thermoregulatory dysfunction with paroxetine
10/14/2014US8859575 Benzoimidazol-2-yl pyrimidine modulators of the histamine h4 receptor
10/14/2014US8859574 Compounds and compositions as kinase inhibitors
10/14/2014US8859573 Pyrimidinone and pyridinone compounds for use in the treatment of diseases or conditions mediated by Lp-PLA2
10/14/2014US8859572 Sulfone substituted 2,3-dihydroimidazo [1,2-C] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases with angiogenesis
10/14/2014US8859571 Quinazoline compounds
10/14/2014US8859570 Maleate salts of a quinazoline derivative useful as an antiangiogenic agent
10/14/2014US8859569 Substituted annellated pyrimidines and use thereof
10/14/2014US8859568 Pyrrolo[3,2-D]pyrimidin-4-one derivatives and their use in therapy
10/14/2014US8859567 Hydrate of 1-{(2S)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di-hydropyrido[3,4-D]pyrimidin-7(6H)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate
10/14/2014US8859566 Substituted fused pyrimidine compounds
10/14/2014US8859565 Compound for inhibiting type 5 phosphodiesterase and preparation method thereof
10/14/2014US8859564 Pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione derivatives useful as inhibitors of phosphodiesterase 1
10/14/2014US8859563 Bicyclic pyrimidinones and uses thereof
10/14/2014US8859562 Use of RNAI inhibiting PARP activity for the manufacture of a medicament for the treatment of cancer
10/14/2014US8859561 Pyrido[4,3-b]indoles and methods of use
10/14/2014US8859560 Treating attention deficit hyperactivity disorder with NHE inhibitors
10/14/2014US8859559 Substituted pyrazines and their use in the treatment of disease
10/14/2014US8859558 Pyrazinyl carboxamides as fungicides
10/14/2014US8859557 Substituted oxindole derivatives and their use as vasopressin receptor ligands
10/14/2014US8859556 TRPA1 receptor antagonist
10/14/2014US8859555 Lysine Specific Demethylase-1 inhibitors and their use
10/14/2014US8859554 Packaging assembly for pharmaceutical composition including pimobendan
10/14/2014US8859553 Protein kinase inhibitors
10/14/2014US8859552 Methods of utilizing arylpiperazine derivatives
10/14/2014US8859551 Compounds, formulations, and methods for treating or preventing inflammatory skin disorders
10/14/2014US8859550 Heterocyclic inhibitors of histamine receptors for the treatment of disease
10/14/2014US8859549 Potassium channel modulators
10/14/2014US8859548 Compounds and compositions as protein kinase inhibitors
10/14/2014US8859547 Pyridazinone derivatives
10/14/2014US8859546 Picolinamide inhibitors of kinases
10/14/2014US8859545 Tetrahydronaphthyridine and tetrahydropyrido[4,3-D]pyrimidine compounds and compositions thereof useful for the treatment of inflammatory and respiratory diseases
10/14/2014US8859544 Indolizine derivatives, process for the preparation thereof and therapeutic use thereof
10/14/2014US8859543 Imidazo[1,2-a]pyrazine derivatives and their use for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases
10/14/2014US8859542 Triazine compounds as PI3 kinase and mTOR inhibitors
10/14/2014US8859540 Use of dihydroimidazolones for the treatment of dogs
10/14/2014US8859539 Compositions of dual thyrointegrin antagonists and use in vascular-associated disorders
10/14/2014US8859538 Uses of substituted imidazoheterocycles
10/14/2014US8859537 Pharmaceutical composition for treating and/or preventing a pathology associated with an obsessional behavior or with obesity
10/14/2014US8859536 Compounds as diacylglycerol acyltransferase inhibitors
10/14/2014US8859535 Hydroxy substituted isoquinolinone derivatives
10/14/2014US8859534 2-carboxamide-7-piperazinyl-benzofuran derivatives
10/14/2014US8859533 Metalloinsertor complexes targeted to DNA mismatches
10/14/2014US8859532 Materials and method for inhibiting replication protein A and uses thereof
10/14/2014US8859531 Pharmaceutical composition including mometasone furoate and azelastine hydrochloride for nasal administration
10/14/2014US8859530 Co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis
10/14/2014US8859529 Compounds for the treatment of inflammatory disorders
10/14/2014US8859528 Compositions and methods for modulation of vascular structure and/or function
10/14/2014US8859527 Inclusion complex of deoxypodophyllotoxin of cyclodextrin, preparation method, use for treatment of cancer thereof
10/14/2014US8859526 Methods for treating bleeding disorders using sulfated polysaccharides
10/14/2014US8859525 Pharmaceutical compositions comprising mushroom-based polysaccharides and uses thereof
10/14/2014US8859524 Lipid conjugates in the treatment of chronic rhinosinusitis
10/14/2014US8859523 Crosslinked compounds and methods of making and using thereof
10/14/2014US8859519 Methods targeting miR-33 microRNAs for regulating lipid metabolism
10/14/2014US8859515 Treatment of tumor necrosis factor receptor 2 (TNFR2) related diseases by inhibition of natural antisense transcript to TNFR2
10/14/2014US8859514 Modulation of C-reactive protein expression
10/14/2014US8859513 Use of 1-beta-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide for the treatment of infectious salmon anemia
10/14/2014US8859512 Anti-viral pyrimidine nucleoside derivatives
10/14/2014US8859511 Proliferation inhibitor of Helicobacter pylori bacteria
10/14/2014US8859510 Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof
10/14/2014US8859509 Chimeric small molecules for the recruitment of antibodies to cancer cells
10/14/2014US8859508 Application of 5-methyl-1,3-benzenediol or derivatives thereof in the preparation of medicines and functional foods for treatment or prevention of depression
10/14/2014US8859502 Therapy for MLL-rearranged leukemia
10/14/2014US8859491 Glucagon superfamily peptides exhibiting glucocorticoid receptor activity
1 ... 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 ... 7860